Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression

Journal of Women's Health

Volumn 19, Issue 9, 2010, Pages 1727-1732

  Weinberger, Andrea H ^a   McKee, Sherry A ^a   Mazure, Carolyn M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DEPRESSION; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SEX RATIO; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ADULT; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77956386738     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1784     Document Type: Article

References (34)

1. Mastroianni AC, Faden R, Federman D. Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies. Women and health research: Ethical and legal issues of including women in clinical studies. Washington, DC: National Academy Press, 1994:Vol.1.
2. United States Public Health Service. Report of the Public Health Service Task Force on Women's Health issues. Public Health Rep 1985;100:73-106.
3. National Institutes of Health. NIH guide for grants and contracts. Bethesda, MD: National Institutes of Health, 1986.
4. General Accounting Office. Problems in implementing policy on women in study populations. Washington DC: United States Government Accounting Office. Report No. GAO/T-HRD-90-50, 1990.
5. Federal Register. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. 1994:59.
6. Food and Drug-Administration. Guidelines for the study and evaluation of gender differences in the clinical evaluation of drugs. U.S. Federal Register 1993;58:39406-39416.
7. Vidaver RM, LaFleur B, Tong C, Bradshaw R, Marts SA. Women subjects in NIH-funded clinical research literature: Lack of progress in both representation and analysis by sex. J Womens Health Gend Based Med 2000;9:495-504.
8. Ramasubbu K, Gurm H, Litaker D. Gender bias in clinical trials: Do double standards still apply? J Womens Health Gend Based Med 2001;10:757-764.
9. General Accounting Office. Women's health: NIH has increased its efforts to include women in research. Washington, DC: United States General Accounting Office, 2000.
10. Geller SE, Goldstein Adams M, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. J Womens Health 2006;15:1123-1131.
11. Fleisch J, Fleisch MC, Thurmann PA. Women in early-phase clinical drug trials: Have things changed over the past 20 years? Clin Pharmacol Ther 2005;78:445-452.
12. Blauwet LA, Hayes SN, McManus D, Redberg RF, Walsh MN. Low rate of sex-specific result reporting in cardiovascular trials. Mayo Clinic Proc 2007;82:166-170.
13. Dickerson DL, Leeman RF, Mazure CM, O'Malley SS. The inclusion of women and minorities in smoking cessation clinical trials: A systematic review. Am J Addict 2009;18: 21-28.
14. Crane PB, Letvak S, Lewallen L, Hu J, Jones E. Inclusion of women in nursing research (1995-2001). Nurs Res 2004;53: 237-242.
15. Kessler RC, Berglund P, Demler O, et al. National Co-morbidity Survey Replication. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105.
16. Gorman JM. Gender differences in depression and response to psychotropic medication. Gen Med 2006;3:93-109.
17. Klerman GL, Weissman MM. The course, morbidity, and costs of depression. Arch Gen Psychiatry 1992;49:831-834.
18. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990:2524-2528.
19. Wang PS, Simon GE, Kessler RC. Making the business case for enhanced depression care: The National Institute of Mental Health-Harvard work outcomes research and cost-effectiveness study. J Occup Environ Med 2008;50:468-475.
20. Luppa M, Heinrich S, Angermeyer MC, Konig HH, Riedel-Heller SG. Cost-of-illness studies of depression: A systematic review. J Affect Disord 2007;98:29-43.
21. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: How did it change between 1990 and 2000? J Clin Psychiatry 2003;64: 1465-1475.
22. Kessler RC, McGonagle KA, Zhae S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
23. Grant BF, Hasin DS, Chou P, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry 2004;61:1107-1115.
24. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.
25. Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics? Clin Pharmacokinet 2002;41:329-342.
26. Yonkers KA, Kando JC, Cole JO, Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992;149:587-595.
27. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imip-ramine in chronic depression. Am J Psychiatry 2000;157: 1445-1452.
28. Wohlfarth T, Storosum JG, Elferink AJ, van Zwieten BJ, Fouwels A, van den Brink W. Response to tricyclic antide-pressants: Independent of gender? Am J Psychiatry 2004; 161:370-372.
29. Thiels C, Linden M, Grieger F, Leonard J. Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int Clin Psy-chopharmacol 2007;20:1-7.
30. Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P, Danish University Antidepressant Group. Are gender differences important for the clinical effects of antidepressants? Am J Psychiatry 2003;160:1643-1650.
31. Young EA, Kornstein SG, Marcus SM, et al. Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res 2009;43:503-511.
32. Thase ME, Reynolds CF, Frank E, et al. Do depressed men and women respond similarly to cognitive behavior therapy? Am J Psychiatry 1994;151:500-505.
33. Preskorn SH. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet 1997;32(Suppl 1):1-21.
34. Mazure CM, Keita GP, eds. Understanding depression in women: Applying empirical research to practice and policy. Washington, DC: American Psychological Association, 2006.